15th Asia Pacific Oncologists Annual Meeting
Taipei Medical University, Taiwan
Title: The Impact of the effectiveness of GATA3 as a prognostic factor in breast cancer
Biography: Abdulfattah salah Fararjeh
The transcription factor GATA3 plays a significant role in mammary gland development and differentiation. We analyzed expression of GATA3 in breast cancer (BC) cell lines and clinical specimens from BC patients in Taiwan. Semi-quantitative reverse transcriptase (RT)-polymerase chain reaction (PCR), quantitative real-time PCR carried out to determine the mRNA level of GATA3 from 241 pairs of matched tumor and adjacent normal issues from anonymous female donors. GATA3 immunohistochemistry (IHC) staining and H-score were performed (n=25). Inducing and silencing of GATA3 were done by exposure MCF-7 cell line to nicotine or curcumin, respectively. GATA3 expression was detected in most of the estrogen receptor-positive (ER+) tumor specimens (176/241, 73%) compared with paired normal issues (65/241, 27%) (p= <0.001). The GATA3 level was highest in Luminal A and independent t-tests revealed higher GATA3 were associated with ER+ (p = 0.018) and BC stages (stage II, and stage IV). Nuclear protein expression of GATA3 was detected in tumor issues (p=<0.001) with higher H-score in Luminal A patients (p=0.012). Kaplan–Meier survival analyses showed that ER+/progesterone receptor (PgR) + and lower grade BC patients with relatively high GATA3 had better clinical overall survival (OS). GATA3 regulate ERa and BCL-2 as BC luminal subtype markers. Cox univariate and multivariate analyses demonstrated that the expression of GATA3 was an effective predictor of the risk of death. We demonstrated a correlation between GATA3 expression and only ER+ and suggest that a higher GATA3 expression is a good prognostic factor for OS for ER+/ BC patients.